Clinical Trial Update: NTLA-2002 in Adults With Hereditary Angioedema (HAE) [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 clinical trial of NTLA-2002 for hereditary angioedema. The study is currently listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• NTLA-2002 (NTLA-2002)

Snippet

Sponsor: Intellia Therapeutics | Conditions: Hereditary Angioedema | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING